Many Patients With Type 2 Diabetes Stop Meds After a Year :

Often, patients with type 2 diabetes on second-line medication discontinue their therapy within a year, warn US researchers who highlight the need for new prescribing approaches.

Related Keywords

Illinois , United States , California , Stanford University , Chicago , Florida , Miami , Stanford , University Of Miami , American , Rodolfoj Galindo , , American Diabetes Association , Expenditure Panel , Northwestern University Feinberg School Of Medicine , Diabetes Center , University Of Miami Health System , American Journal , Management Care , General Internal Medicine , Northwestern University Feinberg School , Medscape Medical News , Lower When Prescribed , Marilyn Tan , Clinical Associate Professor , Stanford University School , Comprehensive Diabetes Center , Miami Health System , Expenditure Panel Surveys , Medical Care , Medicare Advantage , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , T2dm , 2d , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Receptors , Sulfonylureas Sulphonylureas , Practice Management , Revenue , Insurance , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Patient Safety ,